Actionnariat et activité des initiés pour Kura Oncology, Inc. (KURA): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $11.20 |
| Capitalisation | $994M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-08 | Fulk Jennifer | A-Award | 450,000 | $5.6M |
| 2026-09-08 | Fulk Jennifer | |||
| 2026-08-24 | WILSON TROY EDWARD | P-Purchase | 100,000 | $1.2M |
| 2026-08-21 | Powl Brian T. | S-Sale | 4,345 | $52K |
| 2026-08-19 | Bair Teresa Brophy | S-Sale | 31,487 | $398K |
| 2026-08-17 | WILSON TROY EDWARD | P-Purchase | 100,000 | $1.1M |
| 2026-06-18 | Leoni Mollie | S-Sale | 84,929 | $834K |
| 2026-06-04 | Parks Diane L. | A-Award | 35,000 | $307K |
| 2026-06-04 | VASCONCELLES MICHAEL | A-Award | 35,000 | $307K |
| 2026-06-04 | Hasnain Faheem | A-Award | 35,000 | $307K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $9.7M | $11.4M | $16.1M | $26.1M | $325.5M | $90.7M | $51.8M | $37.3M | $224.5M | $149.1M |
| Placements à Court Terme | $58.1M | $81.7M | $162.9M | $210.8M | $307.8M | $427.3M | $386.2M | $386.6M | $502.9M | $518.1M |
| Créances | $295000 | $216000 | $224000 | $30000 | 0 | 0 | 0 | 0 | 0 | $12.6M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $413000 |
| Actifs Courants | $68.8M | $94.6M | $181.2M | $239.6M | $637.3M | $522.3M | $446.4M | $432.5M | $744.8M | $708.7M |
| Immobilisations Corporelles | $40000 | $10000 | 0 | $278000 | $8.4M | $8.2M | $6.4M | $8.9M | $7.5M | $15.2M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $69.8M | $95.9M | $182.4M | $242.0M | $647.2M | $534.1M | $456.3M | $448.9M | $760.2M | $738.4M |
| Dettes Fournisseurs | $638000 | $1.2M | $3.9M | $3.5M | $2.8M | $3.2M | $1.5M | $2.3M | $1.5M | $5.0M |
| Dette à Court Terme | 0 | $1.5M | 0 | $250000 | $3.0M | 0 | 0 | 0 | $2.6M | 0 |
| Passifs Courants | $5.5M | $10.0M | $13.6M | $15.6M | $26.0M | $22.5M | $24.1M | $35.3M | $78.7M | $117.0M |
| Dette à Long Terme | $7.3M | $5.6M | $7.5M | $7.2M | $4.2M | 0 | $9.2M | $9.3M | $6.9M | $9.7M |
| Passifs Totaux | $12.9M | $16.0M | $21.4M | $23.2M | $36.3M | $27.4M | $36.0M | $51.7M | $346.5M | $564.2M |
| Réserves | -$53.9M | -$89.3M | -$149.7M | -$212.9M | -$302.5M | -$433.0M | -$568.8M | -$721.4M | -$895.4M | -$1.17B |
| Capitaux Propres | $56.9M | $79.9M | $161.0M | $218.8M | $610.9M | $506.6M | $420.3M | $397.3M | $413.6M | $174.1M |
| Dette Totale | $7.3M | $7.1M | $7.5M | $7.8M | $15.0M | $6.9M | $14.0M | $17.2M | $16.6M | $20.5M |
| Dette Nette | -$60.5M | -$86.0M | -$171.5M | -$229.1M | -$618.3M | -$511.1M | -$424.0M | -$406.8M | -$710.8M | -$646.8M |
| Fonds de Roulement | $63.4M | $84.6M | $167.6M | $224.0M | $611.3M | $499.8M | $422.4M | $397.2M | $666.1M | $591.7M |
Santé financière
| Dette / Capitaux propres | 0.50 |
| Ratio de liquidité | 4.73 |
Rentabilité
| Rentabilité des capitaux propres | -207.18% |
| Rentabilité du capital investi | -66.95% |
| Rentabilité des actifs | -50.49% |
| Marge brute | 94.73% |
| Marge opérationnelle | -411.90% |
| Marge nette | -384.30% |
Entreprises liées: BCAX · EYPT · MRVI · PRME · PROK · REPL · RZLT
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de KURA: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions